Evaluation of the use of CGRP monoclonal antibodies (mAbs) in migraine prophylaxis in a private clinic. Headache Med [Internet]. 2023 Jun. 30 [cited 2026 Jan. 22];14(2):83-8. Available from: https://headachemedicine.com.br/hm/article/view/747